AUREON POST-OP PX

Medical testing services that utilize a patent's clinical, molecular and morphometric information for predicting the probability of clinical failure post prostatectomy or biopsy in the absence of other treatment and predicting a patient's progression of disease and providing information useful to a doctor in prescribing a recommended therapy